ELEDON PHARMACEUTICALS INC
ELDN·28617K101·US·Common Stock·Healthcare - Biotechnology-13D/G
ELDN (ELEDON PHARMACEUTICALS INC) is held by 62 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($13.5M), VANGUARD CAPITAL MANAGEMENT LLC ($10.1M), Ensign Peak Advisors, Inc ($7.6M). Net institutional sentiment: Mixed.
62
Holders
Avg rating(17 Elite)
$60M
Total Value
66% (71)
Fund Consensus
43 buying - 22 selling
Who's Trading
ActivistBLBVF PARTNERS L P/IL10.0%May 15, 2026
ActivistCOCoastlands Capital LP5.0%Feb 13, 2026
13F: Insider & Congress:
Showing 1-20 of 71
1 / 4
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
413 holders · $666.6B
UNHUNITEDHEALTH GROUP INC413 holders · $186.3B
JNJJOHNSON & JOHNSON394 holders · $391.3B
DHRDANAHER CORP DEL392 holders · $97B
ISRGINTUITIVE SURGICAL INC391 holders · $123.5B
TMOTHERMO FISHER SCIENTIFIC INC391 holders · $147B
BSXBOSTON SCIENTIFIC CORP389 holders · $76.8B
MRKMERCK & CO INC385 holders · $208.9B
ABBVABBVIE INC381 holders · $254.9B
ABTABBOTT LABORATORIES380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer